symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
DRUG,1.56,1.783065,583090,5884429,0,1.43-7.4,-0.02,Bright Minds Biosciences Inc.,USD,0001827401,CA10919W1086,10919W108,NASDAQ Capital Market,NASDAQ,Biotechnology,https://brightmindsbio.com,"Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.",Mr. Ian  McDonald,Healthcare,CA,,647 407 2515,1500 â€“ 1055 West Georgia Street,Vancouver,BC,V6E 4N7,,0,https://financialmodelingprep.com/image-stock/DRUG.png,2021-03-22,False,False,True,False,False
